Your browser doesn't support javascript.
loading
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.
Sharma, Priyanka; Stecklein, Shane R; Yoder, Rachel; Staley, Joshua M; Schwensen, Kelsey; O'Dea, Anne; Nye, Lauren; Satelli, Deepti; Crane, Gregory; Madan, Rashna; O'Neil, Maura F; Wagner, Jamie; Larson, Kelsey E; Balanoff, Christa; Kilgore, Lyndsey; Phadnis, Milind A; Godwin, Andrew K; Salgado, Roberto; Khan, Qamar J; O'Shaughnessy, Joyce.
Afiliação
  • Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City.
  • Yoder R; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • Staley JM; Department of Cancer Biology, University of Kansas Medical Center, Kansas City.
  • Schwensen K; The University of Kansas Cancer Center, Kansas City.
  • O'Dea A; The University of Kansas Cancer Center, Kansas City.
  • Nye L; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Satelli D; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Crane G; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Madan R; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • O'Neil MF; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Wagner J; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • Larson KE; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • Balanoff C; Department of Surgery, University of Kansas Medical Center, Kansas City.
  • Kilgore L; Department of Surgery, University of Kansas Medical Center, Kansas City.
  • Phadnis MA; Department of Surgery, University of Kansas Medical Center, Kansas City.
  • Godwin AK; Department of Surgery, University of Kansas Medical Center, Kansas City.
  • Salgado R; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City.
  • Khan QJ; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City.
  • O'Shaughnessy J; The University of Kansas Cancer Center, Kansas City.
JAMA Oncol ; 10(2): 227-235, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37991778
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Neoplasias de Mama Triplo Negativas Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Neoplasias de Mama Triplo Negativas Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article